2012
DOI: 10.1016/j.pnpbp.2012.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 35 publications
(24 citation statements)
references
References 33 publications
1
23
0
Order By: Relevance
“…4) Although an early study reported that the 5-HT 6 antagonist Ro 04-6790 failed to affect haloperidol-induced catalepsy, 33) we recently demonstrated that the 5-HT 6 antagonist SB-258585 alleviated haloperidol-induced bradykinesia and catalepsy. 29,30) In addition, the EPS-potentiating action of 5-HTP was also blocked by systemic injection of SB-258585 or its microinjection into the striatum, implying that blockade of the striatal 5-HT 6 receptors is at least in part involved in alleviating antipsychotic-induced EPS (Fig. 2 and Table 1).…”
Section: -Htmentioning
confidence: 95%
See 1 more Smart Citation
“…4) Although an early study reported that the 5-HT 6 antagonist Ro 04-6790 failed to affect haloperidol-induced catalepsy, 33) we recently demonstrated that the 5-HT 6 antagonist SB-258585 alleviated haloperidol-induced bradykinesia and catalepsy. 29,30) In addition, the EPS-potentiating action of 5-HTP was also blocked by systemic injection of SB-258585 or its microinjection into the striatum, implying that blockade of the striatal 5-HT 6 receptors is at least in part involved in alleviating antipsychotic-induced EPS (Fig. 2 and Table 1).…”
Section: -Htmentioning
confidence: 95%
“…[28][29][30] Recent clinical studies also showed that ondansetron significantly reduced the incidence and severity of antipsychotic-induced EPS (e.g., akathisia and parkinsonism) in patients with chronic schizophrenia. 31,32) In our studies, activation of the serotonergic system by 5-hydroxytryptophan (5-HTP) significantly potentiated haloperidol-induced catalepsy and this 5-HTPpotentiated EPS was also suppressed by systemic treatments or intrastriatal microinjections of ondansetron.…”
Section: -Htmentioning
confidence: 99%
“…For the evaluation of bradykinesia induction, a pole-test was carried out as described previously (Ohno et al, 1994(Ohno et al, , 2008Tatara et al, 2012). Mice were placed head-upward at the top of a wooden pole (8 mm in diameter and 45 cm height), and then the time for the animal to rotate downward completely (T turn ) and descend to the floor (T total ) was measured with a maximum limit of 90 s. Bradykinesia was evaluated as the prolongation of T turn and T total values.…”
Section: Pole-testmentioning
confidence: 99%
“…The catalepsy-test was carried out as described previously (Ohno et al, 2008;Tatara et al, 2012). Briefly, the forepaws of the mice were placed on a horizontal bar positioned 5 cm above the bench surface, and the time taken for the animals to show a cataleptic posture, which was defined as an immobile posture while keeping both forelimbs on the bar, was measured with a maximum limit of 60 s. AD-6048 (0.1-10 mg/kg, s.c.), HAL (0.03-3 mg/kg, s.c.) or vehicle was administered to the mice 30 min before the catalepsy-test.…”
Section: Catalepsy-testmentioning
confidence: 99%
“…Symptom relief is the goal for the treatment of PMS and it is generally acknowledged that serotonergic antidepressants, including citalopram, escitalopram, fluoxetine, sertraline and venlafaxine, are the first-line pharmacological therapies (2)(3)(4). However, these treatments are limited by their cost and the severe side effects associated with long-term medication regimens (5)(6)(7). Therefore, studies to develop novel pharmacological agents with improved therapeutic effects and fewer side effects are highly important.…”
Section: Introductionmentioning
confidence: 99%